Clinical Trial Update: A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics [Phase 1]

View source ↗

Summary

Phase I study of Anlotinib in patients with advanced cancer has been completed, focusing on tolerability and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED